Brad Lang

Dr. Lang has extensive background in drug discovery and development of therapeutics for neurological diseases and injuries. Dr. Lang previously served as a scientist on the regenerative medicine team at Athersys focused on clinical advancement of its MultiStem system for ischemic stroke. Dr. Lang is a scientific founder of Nervgen and inventor of Intracellular Sigma Peptide, Dr. Lang received his B.S. in Biology from the University of Wisconsin-Madison and his PhD in Neurosciences from Case Western Reserve University.